.dropcap {float:left; color:#4791d2; font-size:75px; line-height:60px; padding-top:4px; padding-right:8px; padding-left:3px; font-family:Georgia}

Google+ Followers


Wednesday, June 17, 2015

The 90% Bogus and Dangerous Female Libido Drug │ Monsanto Silencing American Scientists │ Warning About Digoxin Heart Medication

My wife Jack made a visit home from Vancouver last evening, showing up around 10:20 p.m. ─ my younger brother Mark was still watching the CBC news programme The National.

But he was prompt about retiring to his bedroom around 10:30 p.m. as is his wont.

Jack had brought a dish that she had prepared earlier, and set about arranging some portions of turkey in a roasting pan ─ spicing them up nicely ─ that she left in the fridge for me to put into the oven this afternoon.

I can't help but love the gal ─ she just phoned me (around 4:45 p.m.) to see if I had started to cook the turkey yet, and checking also to see if I had removed a plastic-wrap that she had covered the roasting pan with, just under the lid.

I guess she thought that I might not notice it and just put the whole container into the oven.

However, I was instructed last night to add a couple of chopped-up onions before starting to cook the turkey ─ and an hour or so later, also add some potatoes and carrots; so I would have needed to have been with far poorer vision than I presently suffer to have failed to notice and remove the plastic wrap.

I enjoy our bouts of telephone banter on these occasions.

Incidentally, I also let her know that her 17-year-old son Pote was lying in his bed in the boys' den area with a girl, and that the lights in that area were turned off.

Jack claimed that they are only watching videos on the laptop, and she is thus is not particularly perturbed.

All I can say is that I will be unusually pleased when 20-year-old Tho arrives home from work.  He can monitor his brother from that point.  

Anyway ─ returning to last night ─ I was in bed before midnight once Jack left to return to Vancouver.

I honestly marvel that she has the stamina to be driving all the way out here to Surrey; and then commence the return trip less than 30 minutes later.  I pray no harm ever befalls the woman.

My day today started after I rose around 7:50 a.m.  It was apparent that our hot weather would be continuing.

Much of my morning was spent working on a new post at my Lawless Spirit website; I will finish the post and publish it tomorrow.

I think it was at least noon before I finally found the resolve to tackle the one-arm knee-curls with my 42½ dumbbell ─ I was afraid of them.  I haven't been feeling too hale in the forenoon these past couple of days.

I was a little later getting outside to sun than I intended because of finding myself tied up with a nasty issue involving Kodak Easyshare software that I had uploaded from a 2005 CD yesterday.  I had ignorantly assumed that I needed to upload the software in order to access the photos that were on that CD.

The upload resulted in the installation of Quicktime and its related files.

Over and over I would try to delete the Quicktime file using my control panel and also CCleaner; but even though the process was announced as being successful, the damned file was still clearly there.

The fallout of having it present was this:
(The color scheme has been changed)
The following program has performed an action that requires Windows to temporarily change the color scheme to Windows Basic 7.
Program: qttask.exe
Publisher: Apple Computer Inc.
Windows will automatically change the color scheme back to Windows Aero when this program or other programs performing similar actions are no longer running.
The change was evident in more than just the color scheme.  I had to work without benefit of the three icons in the upper right of my Firefox browser:  the minimize, the maximize, and the close features or options.

If I put my cursor where they were supposed to be, however, and right-clicked my mouse, the options were part of a drop-down that would appear.  So I could still perform those actions.  It was just a big nuisance.

I finally had to 'untick' the box beside the 'QuickTime Task' programme when I checked to see what processes ran at start-up; and then I went into C:\Program Files (x86) folder and manually deleted anything to do with Quicktime or qttask.exe ─ and maybe even Kodak, if it was there (I now forget).

All was well when I re-started my computer thereafter.

But the whole episode took time to research and figure out.

At least now I know that I can just transfer the Pictures folder from out of the CD by right-clicking the CD image when I open up the Computer drive, after clicking the Start Windows globe at the lower left of my Windows 7 taskbar.


I was nearly disgusted to read a report today concerning how a pharmaceutical corporation and its interested allies conned and bullied the weak FDA into probably approving a weakly effective and dangerous libido drug for women.

Believe it or not, this ridiculous drug has been shown to help just one out of every 10 women, yet an even larger percentage than that suffered nasty side-effects while using it in a trial. 

So there's a 1-in-10 chance it may work for any candidate trying it; but a 1½-in-10 chance that the side-effects associated with taking it will force a woman to quit using it.

It's that bad!

This report is from the Health Sciences Institute (HSI) and was released a week ago:

Not so pretty in pink
It's being called the "female Viagra" or even the "little pink pill."

But ADDYI (flibanserin), a new libido drug, is about to become a red hot mess for millions of American women.

An FDA advisory committee last week voted 18-6 to recommend that the agency approve ADDYI -- a move that could come in just a couple short months.

Drug maker Sprout Pharmaceuticals and women's groups are calling it a win, saying that with male sex drugs like Viagra and Levitra on the market, it's about time we ladies got our turn.

But this isn't a victory for science... for common sense... or for women.

Because ADDYI is on the brink of approval thanks to one of the slimiest public relations campaigns in recent history. And the FDA may be ready to greenlight a drug that will fail nine of every 10 women who take it, and may leave a deadly wave of cancer in its wake.

The only thing ADDYI has ever been successful at is generating headlines. But in terms of safety and performance, it has a failure rate that would rival just about any dud drug ever submitted to the FDA.

The med was first developed by Boehringer Ingelheim several years ago as an antidepressant. But it didn't work.

So after some experiments with mice, the company decided... with much fanfare... to repackage ADDYI as a libido-boosting drug for women.

Only the drug failed in that department, too. In clinical trials ADDYI only worked for about 10 percent of the women who tried it, but 15 percent had to quit because of side effects like nausea, dizziness, dangerously low blood pressure and fainting.

That's right -- ADDYI was actually proven more likely to cause side effects than give your sex drive a boost.

Worse still, an animal study linked ADDYI to breast tumors -- the higher the dose, the more tumors researchers were finding.

ADDYI's test results were such a train wreck that the FDA initially said there was a "fundamental question" about whether the benefits of the drug outweighed the risks. That's why the same FDA advisory panel that just approved ADDYI overwhelmingly rejected it in 2010 and again in 2013.

And those rejections sparked a shameful PR campaign that used countless women as drug company pawns.

Boehringer hired Ogilvy Public Relations -- one of the most expensive marketing agencies in America -- to launch a campaign about how women are discriminated against when it comes to sexual dysfunction. They set about trying to convince America that the FDA -- which was run by Dr. Margaret Hamburg at the time -- was the modern-day equivalent of some woman-hating boy's club.

They invented sham women's groups, hired celebrity spokespeople, and even funded their own television propaganda.

Boehringer paid for and supervised a phony documentary about female sexuality that aired three times on the Discovery Channel in 2010.

And when Boehringer sold the rights to ADDYI to Sprout Pharmaceuticals a few months later, things only got worse. Women were bussed around the country to speak out for equal rights, as part of what one women's health expert called a "slick pharmaceutical campaign masquerading as a grassroots feminist movement."

There was a new website called "Your Voice, Your Wish" with videos and petitions. But that website wasn't a voice for American women -- it was a mouthpiece for Sprout, which plans to make billions selling ADDYI to every female consumer it can reach.

Of course, not every women's group was sold on ADDYI or the ridiculous argument that its approval was some battle of the sexes.

In a recent Washington Post op-ed, Cindy Pearson, executive director of the National Women's Health Network, couldn't hide her disgust that the FDA advisory panel finally bowed to political pressure and gave ADDYI the go-ahead. And she points out that the drug's approval, which could come as early as August, could be a nightmare scenario for women.

Because, of course, all of Boehringer's and Sprout's slick marketing hasn't made the drug any more effective -- and it can't wash away ADDYI's links to cancer and other debilitating side effects.

"Every woman deserves to have positive sexual experiences without risking her physical health," Pearson wrote.

Now that's a women's rights campaign we could all get behind.
Talk about gullible weaklings.

Apparently Health Sciences Institute (HSI) were on quite a roll in reporting on corporate bullies a week ago ─ they also did a feature on Monsanto that almost made me furious.  It was definitely offensive activity to be learning about, but not at all surprising where Monsanto are concerned.

'Crucial to the public interest'
Just five years ago, Argentinian researcher Dr. Andreas Carrasco published a paper on Monsanto's herbicide Roundup that threatened his reputation -- and even his life.

He discovered that low doses of Roundup were causing birth defects in frogs and chickens. A violent mob prevented him from giving a talk on his research and beat up students who'd come to hear him speak. A group of thugs even showed up at his office to interrogate him.

It's the kind of thing you don't want to imagine happening in America. But it looks like pro-Roundup thugs have now infiltrated our government -- and they're working for the USDA.

Because a group representing USDA employees claims that agency scientists are being intimidated and are having their careers threatened for trying to expose the dangers of Roundup and other agricultural chemicals. And they're fighting back against a government-sponsored campaign that's protecting Monsanto's billions in profits instead of your health.

Scientists are supposed to ask questions and find answers. It's what they do.

But when USDA scientists found themselves being investigated and censured by higher-ups simply for looking into the effects of Roundup and other chemicals, it was too much for those who look out for their interests -- and ours.

Public Employees for Environmental Responsibility (PEER), which represents USDA and other federal scientists, has recently filed a petition demanding that agency put an end to the censorship and intimidation.

PEER Executive Director Jeff Ruch noted that at least 10 USDA scientists have come forward and claimed that they were ordered to retract studies, delete their names from or delay publication of research papers, and water down findings that conflict with industry interests.

These scientists, Ruch says, "have very little in the way of legal rights and have career paths that are extremely vulnerable."

As one USDA scientist (who asked not to be named) recently told Reuters, "Your words are changed, your papers are censored or edited or you are not allowed to submit them at all." He was talking about research involving the effects of Roundup, which is sprayed on GMO crops, and neonicotinoid insecticides.

And given that the World Health Organization declared Roundup to be a probable cause of cancer in humans, you can just imagine what our government scientists are turning up.

Perhaps the censorship should come as no surprise, given that Secretary of Agriculture Tom Vilsack was praised by President Obama as a promoter of biotech. And when he was governor of Iowa, he was a major booster of Monsanto.

The action by PEER, in turn, has prompted another organization, U.S. Right to Know, to demand that the U.S. Senate and House Agriculture Committees and the USDA's Inspector General investigate whether the pressure on the scientists represented a possible cover-up on Monsanto's behalf.

"It is intolerable that the agribusiness and agrichemical should be able to interfere with USDA scientists and their work," wrote USRTK Executive Director Gary Ruskin. "Those scientists work for the public, not Monsanto nor the agrichemical industry."

Ruskin added that it's "crucial to the public interest" that scientists be allowed to conduct their research "without industry harassment or obstruction" -- even if that means jeopardizing the billion-dollar interests of companies that spend a fortune on lobbying and campaign contributions, like Monsanto.

Unfortunately, we already know that Monsanto will go to any lengths to discourage outside scientists from examining its products. For example, its agreement with farmers who purchase its patented seeds stipulates that they may not transfer those seeds to anyone for "research, or generation of herbicide registration data."

Of course, government scientists haven't made any such agreement to keep Monsanto's dirty secrets. But it's starting to look like the people who sign those scientists' paychecks may have.
Yes, utterly disgusting ─ both reports.

By the way, the Health Sciences Institute (HSI) are a member site of NewMarketHealth.com.

It seems to me that Dr. William Campbell Douglass II reported on a heart-treatment drug called digoxin not too very long ago.  I guess he's just re-emphasizing the danger of this medication ─ by all means, avoid it if you can.

The 'heart drug' that can STOP your heart dead in its tracks
If you're a heart patient with either heart failure or atrial fibrillation, it can feel as if the Grim Reaper is always lurking just outside your door. But if he DOES come calling it may not be because of your condition.

It could be because of the treatment!

New research confirms the warning you read first right here in The Daily Dose -- one of the most commonly used drugs in certain heart patients can actually make it MORE LIKELY that death will come banging on your door.

Overall, the drug digoxin will increase the risk of death in heart patients by more than a fifth. But among those most likely to get the drug -- patients with the hopping-skipping-jumping heartbeat condition known as atrial fibrillation -- the risk of death jumps by 29 percent, according to the analysis of 19 studies.

This same med is often given to heart failure patients, and that's another huge mistake -- because in them, it can increase the risk of death by 14 percent.

On the bright side, this shockingly bad news is the best news digoxin has had in ages: At least TWO studies in recent years found that the drug can increase the risk of death in A-fib patients by more than 70 percent.

Digoxin has a lot in common with another dangerous drug given to heart patients, the blood thinner warfarin. Both have been used as rat poison, and both are so risky for humans that anyone who takes either one requires regular tests to ensure they don't take too much.

How much is too much? If you ask me, ANY amount is... and I think that's pretty clear from the study.

Too many patients are taking it and taking it daily.

You don't have to be one of them. There's a much better way to get control of A-fib, and you can start with two to three tablespoons per day of cod liver oil.

But this is a serious condition of course, so don't take matters into your own hands. Work closely with your doctor, ideally an experienced naturopathic physician.

With a heart, skip and a jump,

William Campbell Douglass II, M.D.
The recent published study he referred to is probably this:  Digoxin-associated mortality: a systematic review and meta-analysis of the literature (DOI: 10.1093/eurheartj/ehv143).

Here are a couple of other reports on that same study:
The cod liver oil Dr. Douglass recommended should have been a daily supplement since childhood ─ or at least, a hearty tablespoon of it, at any rate.  There probably wouldn't be anywhere near the number of heart problems if this was a common regimen for families like the oil once was.


To close off today's edition, I have three photos to offer that were likely taken in the Summer of 2005.  They are actually three of the photos I captured from that infernal Kodak CD I spoke of earlier.

The first two photos are of my niece Rene wading across the Similkameen River in Keremeos where my mother Irene Dorosh was then living.  The river was little more than a stone's throw from my mother's home.

Rene (her actual first name is Irene) is now 21 years old, so I reckon she was 11 in the photos.

And this is her, my mother Irene, myself in the white cap, and my younger brother Mark:

Mark, Rene, and I may have been preparing to leave after having spent at least a night in my mother's home.  We usually only visited her on a long weekend.

Unfortunately, this was to be the final year of my mother's life ─ she died alone of an aneurism mid-March 2006 at the age of 89.

We ─ along with my older maternal half-sister Phyllis ─ had planned on surprising my mother with a visit to celebrate her 90th birthday (which would have been on May 6, 2006)...but it was not to be.

I miss that lovely old girl so much.
Post a Comment